276 related articles for article (PubMed ID: 26188862)
21. Equine recurrent uveitis: the viewpoint from the USA.
Gilger BC
Equine Vet J Suppl; 2010 Mar; (37):57-61. PubMed ID: 20939168
[TBL] [Abstract][Full Text] [Related]
22. Equine recurrent uveitis: new methods of management.
Gilger BC; Michau TM
Vet Clin North Am Equine Pract; 2004 Aug; 20(2):417-27, vii. PubMed ID: 15271431
[TBL] [Abstract][Full Text] [Related]
23. The role of Leptospira spp. in horses affected with recurrent uveitis in the UK.
Malalana F; Blundell RJ; Pinchbeck GL; Mcgowan CM
Equine Vet J; 2017 Nov; 49(6):706-709. PubMed ID: 28321895
[TBL] [Abstract][Full Text] [Related]
24. [Detection of leptospira by culture of vitreous humor and detection of antibodies against leptospira in vitreous humor and serum of 225 horses with equine recurrent uveitis].
Dorrego-Keiter E; Tóth J; Dikker L; Sielhorst J; Schusser GF
Berl Munch Tierarztl Wochenschr; 2016; 129(5-6):209-15. PubMed ID: 27344913
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis.
Regan DP; Aarnio MC; Davis WS; Carmichael KP; Vandenplas ML; Lauderdale JD; Moore PA
Vet Ophthalmol; 2012 May; 15(3):145-52. PubMed ID: 22051225
[TBL] [Abstract][Full Text] [Related]
26. [Depiction of the structure of the vitreous body in horses without ocular diseases and in horses with equine recurrent uveitis (ERU) using transmission electron microscopy].
Niedermaier G; Wollanke B; Hoffmann R; Matiasek K; Gerhards H
Dtsch Tierarztl Wochenschr; 2006 Jun; 113(6):211-7. PubMed ID: 16856605
[TBL] [Abstract][Full Text] [Related]
27. [Detection of leptospira in the vitreous body of horses without ocular diseases and of horses with equine recurrent uveitis (ERU) using transmission-electron microscopy].
Niedermaier G; Wollanke B; Hoffmann R; Brem S; Gerhards H
Dtsch Tierarztl Wochenschr; 2006 Nov; 113(11):418-22. PubMed ID: 17147152
[TBL] [Abstract][Full Text] [Related]
28. Immunological and pathological investigations in equine experimental uveitis.
Simeonova GP; Krastev SZ; Simeonov RS
Vet Res Commun; 2016 Dec; 40(3-4):107-115. PubMed ID: 27344152
[TBL] [Abstract][Full Text] [Related]
29. Cytokine and chemokine profiles of aqueous humor and serum in horses with uveitis measured using multiplex bead immunoassay analysis.
Curto E; Messenger KM; Salmon JH; Gilger BC
Vet Immunol Immunopathol; 2016 Dec; 182():43-51. PubMed ID: 27863549
[TBL] [Abstract][Full Text] [Related]
30. [Demonstration of intraocular leptospira in 4 horses suffering from equine recurrent uveitis (ERU)].
Brem S; Gerhards H; Wollanke B; Meyer P; Kopp H
Berl Munch Tierarztl Wochenschr; 1998; 111(11-12):415-7. PubMed ID: 9880935
[TBL] [Abstract][Full Text] [Related]
31. Immunopathology of recurrent uveitis in spontaneously diseased horses.
Deeg CA; Ehrenhofer M; Thurau SR; Reese S; Wildner G; Kaspers B
Exp Eye Res; 2002 Aug; 75(2):127-33. PubMed ID: 12137758
[TBL] [Abstract][Full Text] [Related]
32. Characterization of amyloid in equine recurrent uveitis as AA amyloid.
Ostevik L; de Souza GA; Wien TN; Gunnes G; Sørby R
J Comp Pathol; 2014; 151(2-3):228-33. PubMed ID: 24975895
[TBL] [Abstract][Full Text] [Related]
33. Detection of Leptospira interrogans DNA and antigen in fixed equine eyes affected with end-stage equine recurrent uveitis.
Pearce JW; Galle LE; Kleiboeker SB; Turk JR; Schommer SK; Dubielizig RR; Mitchell WJ; Moore CP; Giuliano EA
J Vet Diagn Invest; 2007 Nov; 19(6):686-90. PubMed ID: 17998558
[TBL] [Abstract][Full Text] [Related]
34. A review of investigated risk factors for developing equine recurrent uveitis.
Kingsley NB; Sandmeyer L; Bellone RR
Vet Ophthalmol; 2023 Mar; 26(2):86-100. PubMed ID: 35691017
[TBL] [Abstract][Full Text] [Related]
35. Genetic risk factors for insidious equine recurrent uveitis in Appaloosa horses.
Fritz KL; Kaese HJ; Valberg SJ; Hendrickson JA; Rendahl AK; Bellone RR; Dynes KM; Wagner ML; Lucio MA; Cuomo FM; Brinkmeyer-Langford CL; Skow LC; Mickelson JR; Rutherford MS; McCue ME
Anim Genet; 2014 Jun; 45(3):392-9. PubMed ID: 24467435
[TBL] [Abstract][Full Text] [Related]
36. Leptospiral antibody prevalence and surgical treatment outcome in horses with Equine Recurrent Uveitis (ERU) in Switzerland.
Voelter K; Vial Z; Pot SA; Spiess BM
Vet Ophthalmol; 2020 Jul; 23(4):648-658. PubMed ID: 32352624
[TBL] [Abstract][Full Text] [Related]
37. [35 leptospira isolated from the vitreous body of 32 horses with recurrent uveitis (ERU)].
Brem S; Gerhards H; Wollanke B; Meyer P; Kopp H
Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):390-3. PubMed ID: 10598357
[TBL] [Abstract][Full Text] [Related]
38. Miscellaneous vitreous-derived IgM antibodies target numerous retinal proteins in equine recurrent uveitis.
Zipplies JK; Hauck SM; Eberhardt C; Hirmer S; Amann B; Stangassinger M; Ueffing M; Deeg CA
Vet Ophthalmol; 2012 Sep; 15 Suppl 2():57-64. PubMed ID: 22432720
[TBL] [Abstract][Full Text] [Related]
39. Equine recurrent uveitis: Lessons from and for autoimmune anterior uveitis in humans.
Hughes KJ
Vet J; 2015 Dec; 206(3):245-6. PubMed ID: 26515164
[No Abstract] [Full Text] [Related]
40. Horses with equine recurrent uveitis have an activated CD4+ T-cell phenotype that can be modulated by mesenchymal stem cells in vitro.
Saldinger LK; Nelson SG; Bellone RR; Lassaline M; Mack M; Walker NJ; Borjesson DL
Vet Ophthalmol; 2020 Jan; 23(1):160-170. PubMed ID: 31441218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
